Clinical implications of the dual blockade of the PD-1/PD-L1 and vascular endothelial growth factor axes in the treatment of hepatocellular carcinoma

Podobne zapisy

• Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma
  od: Calderaro, Julien
  Wydane: (2020)
• Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma
  od: von Marschall, Z, i wsp.
  Wydane: (2001)
• Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade
  od: Aoki, Tomoko, i wsp.
  Wydane: (2020)
• Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma
  od: Deng, Haijing, i wsp.
  Wydane: (2020)
• Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma
  od: Kaseb, Ahmed O., i wsp.
  Wydane: (2011)